Market closed

Ironwood Pharmaceuticals/$IRWD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Ticker

$IRWD
Sector
Health Care
Trading on
NASDAQ

Industry

Biotechnology
Headquarters
Boston, United States

Employees

267
Website
www.ironwoodpharma.com

IRWD Metrics

BasicAdvanced
$603M
-
-$0.02
0.47
-

$603M

0.47

$15.70

$3.06

2.3M

3.617

3.329

-196.477

-197.496

4.11%

18.45%

0.98%

1.575

-1.94

-1.92

4.814

-12.48%

-99.71%

-2.90%

-82.30%

What the Analysts think about IRWD

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Ironwood Pharmaceuticals stock.

IRWD Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IRWD Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

IRWD News

AllArticlesVideos
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Business Wire·2 months ago
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Business Wire·2 months ago
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IRWD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ironwood Pharmaceuticals stock?

Ironwood Pharmaceuticals (IRWD) has a market cap of $603M as of January 15, 2025.

What is the P/E ratio for Ironwood Pharmaceuticals stock?

The price to earnings (P/E) ratio for Ironwood Pharmaceuticals (IRWD) stock is 0 as of January 15, 2025.

Does Ironwood Pharmaceuticals stock pay dividends?

No, Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Ironwood Pharmaceuticals dividend payment date?

Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders.

What is the beta indicator for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals (IRWD) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.